Skip to main content
Clinical Trials/NCT02150538
NCT02150538
Unknown
N/A

BiventRicular Pacing in prolongEd Atrio-Ventricular intervaL: the REAL-CRT Study

Gianluca Botto1 site in 1 country164 target enrollmentSeptember 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
First Degree Atrioventricular Block
Sponsor
Gianluca Botto
Enrollment
164
Locations
1
Primary Endpoint
LVEF
Last Updated
10 years ago

Overview

Brief Summary

This study was designed to evaluate the potential benefits of treatment with biventricular device in patients with normal systolic function , indication for pacing and impaired atrio-ventricular conduction , by comparing the treatment with dual-chamber device . The REAL -CRT study is designed to test the hypothesis that, in patients with atrioventricular block of I degree and standard pacing indications , biventricular pacing is superior to single stimulation of the right ventricle (RV) with optimized algorithms for minimization of pacing , as assessed by echocardiography an endpoint defined in terms of maintenance over time of left ventricular ejection fraction (LVEF ) and left ventricular end-systolic volume ( LVESV ) .

Detailed Description

Clinical data suggest that biventricular pacing is able to preserve the myocardial performance more effectively than the right ventricular pacing in patients with atrioventricular block and mild systolic dysfunction . In particular, some studies have shown that medical therapy in these patients could be responsible for an increase in the cumulative percentage of chronic pacing over the 40% threshold , the threshold associated with a higher incidence of atrial fibrillation and hospitalization for heart failure and ventricular arrhythmias . In addition , patients with pre-existing left ventricular dysfunction and indication for pacing standards have improved left ventricular systolic function , exercise capacity and quality of life as a result of biventricular pacing as compared with Right ventricular pacing . These results suggest that biventricular pacing is a feasible option for permanent pacing in patients who have normal systolic function of the left ventricle and that this can be altered from the adverse effects of conventional Right ventricular pacing on systolic function of the left ventricle . This reality has prompted physicians to assess the value and role of cardiac resynchronization therapy (CRT ) in patients with prolonged Atrio-Ventricular (AV) conduction . Note the deleterious effects of chronic stimulation of the right ventricle , the optimal pacing mode should always be considered in these patients at the time of implantation . This study was designed to evaluate the potential benefits of treatment with biventricular device in patients with normal systolic function , indication for pacing and impaired atrio-ventricular conduction, by comparing it with the treatment with dual chamber device

Registry
clinicaltrials.gov
Start Date
September 2013
End Date
December 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Gianluca Botto
Responsible Party
Sponsor Investigator
Principal Investigator

Gianluca Botto

Head of Electrophysiology Unit

S. Anna Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with standard indications to stimulation with a high probability of paced beats according to the clinical evaluation of the investigators:
  • First degree AV block (PR ≥ 220 ms) and indication for pacing
  • Paroxysmal AV block second degree (Type I and Type II) associated with long-PR (PR ≥ 220 ms)
  • Patient must be able to attend all required follow-up visits at the study center.
  • LVEF\> 35%
  • Exclusion Criteria :
  • Patient is less than 18 years of age.
  • Patients with a life expectancy less than 12 months
  • Indication for CRT in class I and II
  • Third-degree AV block

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

LVEF

Time Frame: 2 years

LVEF (Left Ventricular Ejection Fraction: such as the assessment of systolic function of the left ventricle)

LVESV

Time Frame: 2 years

LVESV (Left Ventricular End Systolic Volume: such as the assessment of left ventricular remodeling)

Secondary Outcomes

  • Echocardiographic altrial measures(2 years)
  • echocardiographic left ventricular measures(2 years)
  • Clinical outcome(2 years)
  • Atrial fibrillation (AF)(2 years)

Study Sites (1)

Loading locations...

Similar Trials